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In view of the recurrent demonstration  that the hemolytic activity of serum 
may  decline  during  experimentally  induced  systemic  anaphylaxis  (reviewed 
in  references  1,  2)  and  in  some naturally  occurring  disease  processes  with  a 
presumed allergic component,  (3, 4),  complement  (C')  has been implicated  in 
the  mediation  of  hypersensitivity  reactions  (5,  6).  Recently,  this  inference 
gained  further  support  when  it  was shown  that  an  induced  C'  deficiency in 
albino  rats  was associated  with  a  diminished  reactivity  to passive cutaneous 
anaphylaxis  (PCA)  (7).  The  evidence emerging  from  the  latter  observations 
did  not  permit  differentiation  between  the  temporal  coincidence  of  the  two 
events  and  a  possible  dependence  of  cutaneous  anaphylaxis  upon  adequate 
levels  of  circulating  C'.  The  present  investigation  was  therefore  undertaken 
in an effort to clarify the relationship between PCA and C'. The data detailed 
below are  in  accord with  the  hypothesis  that  this  immediate  type of allergic 
reaction  may  be significantly  influenced  by variation  of any  one  of at  least 
three  variables,  v/z.,  antigen,  antibody,  and  a  host  factor  which  resembles 
hemolytic C'. 
Materials  and Methods 
Passive Cutaneous Anaphylaxis.-- 
This type of local reaction was selected as the experimental model because of its relative 
reproducibility and ease of quantitation in comparison to systemic anaphylaxis. The follow- 
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ing considerations led to the choice of rats rather than guinea pigs as the experimental ani- 
mals. The hemolytic C' level of rat serum is much lower than that of the guinea pig (ap- 
proximately 40  as compared  to  200  fifty per cent hemolytic units,  (C'H~0), per ml.).  An 
economy was therefore affected in the amount of specific  antibody required for the decom- 
plementation procedure which was an integral part of the experimental approach (of. refer- 
ence  8).  Moreover,  the  resistance  of  these  animals to  generalized  anaphylactic  reactions 
enabled them to withstand the systemic immune reaction used for C' depletion without any 
manifest symptoms of shock. 
The PCA reactions were induced as described below (9). Male albino rats of the Wistar 
strain weighing between  130  and  170 gin. were used in all of these experiments. The hair 
over the abdominal area was gently clipped with an electric shaver without irritating the 
skin. Dilutions of serum containing the designated quantities of antibody in a  volume of 0.1 
ml. were prepared in 0.15 ~x NaCI and injected intracutaneously with tubercuiin-type syr- 
inges of 0.25 ml. capacity equipped with gauge 27 hypodermic needles. A maximum of four 
skin sites per rat were thus prepared.  During the latter part of the study we were informed 
that skin reactions elicited on the dorsal surface were more sharply demarcated than those 
in the abdominal area (10). This observation was confirmed but use of the abdominal area 
was  continued  to  facilitate comparisons  with  the  many  earlier  experiments.  Preliminary 
experiments also confirmed earlier findings that a  2  hour latent period between the intra- 
dermal antibody inoculation and the intravenous injection of dye-antigen mixture resulted 
in maximal skin blueing (11). This latent period was uniformly maintained in all experiments. 
The  dye-antigen  mixture was  prepared  immediately before  injection and  each animal re- 
ceived 0.25 ml. of a  1 per cent solution of Evans blue and the designated quantity of antigen 
in isotonic saline. The total volume of injected material was varied between the limits of 1.2 
and 2.2 ml. As noted below, the saline diluent for the antigen was replaced in some of the 
experiments by  various serum preparations.  The  penile vein was  found  most  satisfactory 
for the intravenous inoculations, although the superficial veins on the paws of the hind feet 
were also used occasionally. The rats were sacrificed 60 minutes after the injection of the dye 
and the skin of the abdomen was carefully stripped from the subcutaneous tissues.  The reac- 
tions were read by measuring the diameter of the blue area on the inner surface of the skin 
with a  transparent millimeter ruler. 
The same time relationships were retained in the experiments with C'-deficient rats. For 
these studies, the animals received an intravenous injection of 1.0 ml. of a  saline dilution of 
serum containing 200 gg.  of rabbit anti-ovalbumin (Ea)  N  and an intraperitoneal inocula- 
tion of 80/~g. of Ea N. These reagents were administered immediately following the prepara- 
tion of  the skin sites for the PCA  reactions. As noted below,  other antigen and antibody 
preparations were occasionally substituted for the ovalbumin immune system in rendering 
the animals deficient in circulating C'. 
A ntiser a and Antigens.-- 
A  variety of rabbit and horse antisera and corresponding protein or polysaccharide an- 
tigens were employed for the induction of PCA reactions and for decomplementation. De- 
tails as to the source and properties of each immune system are described below. All antisera 
were heated at 56°C.  for 30 minutes, clarified by centrifugation at 0°C. and preserved with 
0.01 per cent merthiolate at --20"C. Antibody N  estimations of the sera were carried out by 
the quantitative precipitin method  of Heidelberger and  Kendall as  described in  reference 
12.  Stock solutions of all antigens except chicken ovalbuml-  (Ea)  were prepared in 0.15 M 
NaCI containing 0.01 per cent merthiolate and stored at --20°C. The Ea solutions were also 
prepared in merthiolated saline but were stored at refrigerator temperatures and were freshly 
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¢om  p  lonent.-- 
Fresh guinea pig and rat sera were used as the source of C'.  For the est~ation of hemo- 
lytic potency in sera from individual rats, blood was obtained by puncture of the infra-orbital 
sinus with a clean, dry pipette (13). Fresh normal rat serum for parenteral use was obtained 
by cardiac or jugular puncture of I0 to 20 annals. The pooled serum was clarified by cen- 
tr~ugatinn at 0°C.,  and stored in clean, tightly stoppered pyrex test tubes (13 x  100 ram.) 
at -50°C. 
Fresh guinea pig serum was obtained commercially in the frozen state,  absorbed twice 
at 0°C., with 1 ml. of washed, packed sheep erythrocytes per 30 ml. of serum, and stored 
at  -50°C.  as described above. For some of the experiments, the guinea pig serum was also 
absorbed with washed,  packed  rat  erythrocytes but  this practice was  discontinued when 
comparative studies showed that this procedure did not affect the results. 
Estimations of the hemolytic activity of C' and of the C'-f~ing potencies of the several 
antisera described below were carried out as described in reference 14 with the veronal buffer 
diluent containing 5  X  10  -4 ~s Mg++ and  1.5  X  10  -4 ~  Ca  ++. Similar determinations with 
rat serum as the source of  C'  necessitated some minor modifications of  these procedures. 
Thus, preliminary experiments indicated that the hemolytic potency of rat C' was slightly 
diminished when calcium salts were added to the assay reaction mixtures in final concentra- 
tions as low as 10  -6 ~. Further, a 90 minute reaction period at 37°C. was required to achieve 
maximal lysls in titrations of rat C' activity. Finally, it was necessary to adjust the level of 
rabbit hemolysin for optimal sensitization of  the  sheep erythrocytes in  experiments with 
rat C'. The need to institute these minor adjustments indicates that the cation and antibody 
requirements for maximal efficiency of the hemolytic system comprising sheep erythrocytes, 
rabbit amboceptor, and guinea pig C' are not necessarily optimal for hemolytic studies with 
C' derived from other species. 
C' Corapon~ Re,  agents.- 
These reagents were prepared and tested essentially as described in reference 12 except 
for the modifications noted below: 
1.  Healed C'.--Guinea pig and rat sera in volumes of 5 to 20 mi. were initially heated at 
56°C. for 60 minutes to destroy the first and second components of C', (C'I and C'2), It was 
subsequently found that exposure at this temperature for a  period of 15 minutes sufficed  to 
abolish hemolytic activity.  For example,  one pool of fresh rat serum  contained sufficient 
hemolytic activity so that 0.4 ml. of a  1 --* 100 dilution lysed 50 per cent of l0  s sensitized 
sheep erythrocytes in a  volume of 1.5 nil. When an aliquot of this pool was heated at 56°C. 
for 15 minutes, 1.0 ml. of a  1 ~  10 dilution produced no visible lysls with the same number 
of sensitized red blood cells.  C' component titrations showed that this heated serum had no 
demonstrable C'I or C'2 activity and only about half of the initial C'3 and C'4 potency. 
2.  Zymosan-Treated  C'.--Two  hundred rag.  of zymosan  (Flelschman, lot No.  369)  were 
suspended in 100 ml. of 0.15 ~  NaCI in a  Waring blendor. The suspension was then heated 
in a  boiling water  bath for 60 minutes with intermittent shaking and centrifuged for 30 
minutes at 3000 G  (15).  The clear supematant was  carefully aspirated and  the sediment 
suspended in 10 mi. of isotonic veronal buffer. Preliminary titrations were then performed 
to determine the minimal quantity of this zymosan preparation necessary for the preferential 
destruction of C'3 in fresh guinea pig or rat serum at 37°C. It was found that 1.5 to 5.0 rag. 
of the zymosan suspension per mi. of serum rendered C' devoid of hemolytic activity through 
the  inactivation  of  C'3.  However,  these  quantities  of  zymosan  also  destroyed  varying 
amounts of the C'I and C'4 activities as estimated by component titrations (c.f. references 
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3.  Ammonia and Hydrazine-Tmated  C'.--When NI-Lt0H at a  final concentration of 2  X 
10  -2 M or hydrazine at 3.6 X  10  -~ ~  were added to fresh guinea pig or rat serum, virtually 
all of the C'4 was destroyed (17,  18). This treatment proved more selective than that for the 
other  C'  component preparations in the sense that hemolytic activity of ammonia or hy- 
drazine-treated sera could be restored to the initial levels by the addition of the appropriate 
reagents. 
4.  Specific Decomplementa~ion.--Guinea pig and rat sera were added to washed, preformed 
specific  precipitates for the selective uptake of C'I, C'4, and Cr2. Thus, 5 mg. of rabbit anti- 
bovine gamma globulin N  were reacted with 0.6 mg. of homologous antigen N  for 24 hours 
in the refrigerator. The precipitate was collected and washed four times with 25 ml. of cold 
isotonic NaCI.  The sedimented immune aggregate was then evenly suspended in 25  ml. of 
fresh guinea pig or  rat  serum  and  stored  in  the  refrigerator overnight with  intermittent 
shaking. The reaction mixtures were then clarified by centrifugation at 0°C. for 60 minutes 
at  15,000  G and  the supernates stored  at  --50°C.  Several preparations of  this type  were 
devoid of lyric activity at levels of 1.0 ml. of a  1 --~ 10 dilution. 
It should be emphasized that although the procedures employed for the preparation and 
estimation of C' components conform to current practice, they are subject to several serious 
limitations. The reagents obtained following treatment of fresh normal serum with zymosan, 
ammonia, or heat are neither reproducible in a  strictly quantitative sense, possibly because 
of  the difficulties of  the assay procedures,  nor are  they  uniquely specific for  the selective 
destruction of any given C' component (19-21). These observations are borne out, in part, 
by the continuing efforts over the past two decades, directed towards the purification and 
isolation of the individual components of C' (22-26). In this light, the results obtained with 
these reagents in the present studies are considered as providing essentially qualitative evi- 
dence directed towards the provisional identification of a  host factor which participates in 
PCA of the albino rat. 
EXPERIMENTAL  RESULTS 
A. PCA Response as a Function of Antigen and Antibody Conc~tr~ions 
The data  in Table I  and  Fig.  1 summarize the results of numerous experi- 
ments in which the magnitude  of the dermal reaction  was studied  at several 
levels of rabbit anti-pneumococcus  Type III serum and increasing quantities 
of the  type-specific  capsular polysaccharide,  SIII.  These findings,  as  well as 
those obtained  with rabbit  anti-Ea  reacting  with intravenously  injected  Ea, 
indicate  a reciprocal relationship  between the levels  of antigen  and antibody 
required  to elicit blueing  of the rat  skin.  Several  observations  emerge  from 
these data.  For the experimental conditions  employed  in this study, it appears 
that 6.0 ~g. of SIII represents the threshold antigen  level  which will produce 
an unequivocal  PCA reaction in the rat skin injected  2 hours previously  with 
at least 3.5 ~g. of anti-SIII N. The magnitude of the response at each antibody 
level  increases  as  more  antigen  is  used  reaching  an  apparent  maximum  at 
approximately  48 ~g. of SIII. These data also confirm previous findings in the 
demonstration  that with a large excess of antigen,  the rat requires about 100 
times more  antibody  than  does  the guinea  pig for a  minimal  PCA reaction 
(11). As judged from examination  of the rat skin in the living animal,  the rate 
of blueing  at the site increases  with greater quantities  of immune  reactants. OSLER,  HAWRISIAK,  OVARY, SEQUEIRA~ AND  BIER  815 
Since the total amount of antibody N  in the four skin sites for each rat de- 
picted in Table I  approximates 16 pg., it appears that maximal PCA responses 
require  a  considerable excess of antigen  in  terms of the  precipitin reaction, 
if it is  assumed that all of the injected antigen is available for the reaction. 
Similar observations have been reported for systemic and passive cutaneous 
anaphylaxis in the guinea pig  (27, 9). 
TABLE I 
PCA Responses in Normal Rats with Varying Quantities of Rabbit Anti-Sill 
N (R3 -- 175)* Reacting with SIII~ Dissolved in Saline§ 
Rabbit auti-SIII N injected  intradermally,  pg. per skin site 
SIIl in saline  int,avoooosiy  I  5.3  I  3.5  I  2.6  I  ,.2]0., 
Average diameter  of response,  mm. 
~g 
1.5 
3.0 
6.0 
12.0 
24.0 
48.0 
96.0 
192.0 
0.4  (8)][ 
1.4  (22) 
8.5  (57) 
13.8  (56) 
18.1 (33) 
21.5  (4) 
18.5  (4) 
19.5 (4) 
22.8  (4) 
14.8  (4) 
15.5 (4) 
0  (8) 
2.2  (22) 
6.3  (57) 
10.8  (52) 
14.8  (25) 
18,5 (4) 
140  (4) 
14.5  (4) 
0  (8) 
1.1  (22) 
3.2  (57) 
5.8  (52) 
9.3  (29) 
14.8  (4) 
8.8  (4) 
11.0  (4) 
0  (8) 
0.4  (22) 
1.7  (57) 
2.1  (48) 
5.1  (25) 
* This serum was obtained through the courtesy of the New York State Department of 
Health and contained 5.26 mg. anti-SIII N per ml. after absorption with the "C" substance 
of Type II pneumococci. 
:~ We are  grateful to Dr.  M.  Heidelberger for the type-specific pneumococcus polysac- 
charides used in these studies. 
§ The degree of variation in PCA reactions between rats diminished as the amount of 
antigen and antibody used to elicit them was increased. Thus, the range of variation for PCA 
provoked with 6/ag. SIII and 3.5/~g.  anti-SIII N was 0 to 20 mm. with a standard deviation 
of 6.6 ram. The range for the reactions induced with 24  /~g. SII1 and 10.5 pg. anti-SIII N 
was 10 to 25 ram. with a standard deviation of 3.5. 
[] The figure  in parenthesis indicates the number of rats used for each determination. 
B. PCA Response as Influenced by the Addition of Fresh Normal Serum to the 
Antigen-Dye Mixture 
In earlier studies on PCA reactions in the albino rat, a parallelism was noted 
between the intensity of the local cutaneous response and the levels of circu- 
lating C' activity (7). If this correlation of the two phenomena implied a casual 
relationship, it might be anticipated that an increase in available C' would be 
associated with enhanced PCA reactions. Accordingly, a series of experiments 
was  designed,  similar  in all respects to those summarized in Table I  except 
that the antigen-dye mixture was incorporated in fresh rat or guinea pig serum 816  MECHANISM  OF  HYPERSENSITIVITY  PHENOMENA.  II 
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TABLE II 
PCA Responses  in Normal Rats wilh Varying Quantities  of Rabbit Anli-SIlI  N  (R= --  I75) 
Reacling  u,ith SIH Dissolved in Fresh Rat or Guinea Pig Serum* 
SIII injected 
intravenously  with 
1 to 2 ml. of fresh 
rat or guinea 
pig  serum 
/~g. 
1.5 
3.0 
6.0 
12.0 
24.0 
Rabbit anti-SIII N injected intradermally,  #g. per skin site 
,o,  I  ,,  I  ,,12ol  ,,  I  o, 
Average diameter of response, ram. 
0.6  (12):i:  I 
7.7  (20) I 
1s.4  (28)] 
20.4  (18) 
24.5  (12)  21.1  (s) 
0  (12) 
6.2  (20) 
9.7  (28) 
17.1 (18) 
18.0  (4)  19.s  (s) 
0  (12) 
4.4  (2o) 
6.5  (28) 
10.o  (18) 
14.1  (12) 
0  (12) 
1.6  (20) 
4.0  (2z) 
7.1  (18) 
s.s  (4) 
* Since the enhancing effect and the range of variation induced by fresh guinea pig or rat 
sera were similar, the data have been combined. 
:~ The figure in parenthesis indicates the number of rats used for each determination. OSLER~ HAWRISIAKy  OVARY~ SEQUEIRA~ AND BIER  817 
instead  of isotonic saline.  The results  of these experiments are  tabulated  in 
Table II. Both the rat and guinea pig sera potentiated the local anaphylactic 
response at each level of antigen or antibody tested (of.  Tables I  and II, Figs. 
2 and 3). Moreover, the threshold SIII level for minimal PCA reactions was 
reduced from 6.0 to 3.0 ~g.  when fresh serum replaced the saline diluent for 
the antigen. It was also of interest to note that guinea pig serum was not more 
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uniformly effective than that of the rat despite its greater hemolytic activity. 
This observation may perhaps be attributed to the slight toxicity associated 
with the intravenous injection of foreign serum. 
The enhancing effect of fresh rat serum was also observed in an experiment 
summarized by the data in Table III. 
In this case, each of 20 rats received five intradermal injections of antibody. Two sites 
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TABLE  11I 
The Effect of Fresk Serum on PCA Reactions  Induced in Rats by Homologous and 
Heterologous Rabbit A nti-Pneumococcus  Sera Reacting  w~th S VHI 
Sera*--Rabbit anti-pneumococcus Type  III,  ST]:).  No.  1  containing  1.36  rag.  of anti- 
SIII N  and 0.035  rag. of anti-SVIII N  per ml. Rabbit anti-pneumocoecus Type  VIII,  R8- 
76 containing 3.05 mg. of anti-SVIII N  per ml. 
SVIII  injected  intravenously 
P~g. 
50 in saline ................... 
100 in saline .................. 
200 in saline .................. 
200 in fresh rat serum ......... 
Heterologous anti-SVIII N (STD. No. 1), [ 
/~g. per skin site 
7.0:  l  3.5  I  1.8 
Homologous anti-SVlII N 
P,8-76,/~g. per skin site 
5.0  I  2,5 
Average diameter of skin response, ram. 
1 
0  (4)§ I  0  (4) 
6.2  (4)  2  (4) 
is.:  (6)  6.2  (6) 
20.2  (6)  16.1  (6) 
0  (4) 
2  (4) 
2.7  (6) 
12.2  (6) 
17.5  (4) 
19  (4) 
1s,2  (6) 
18.7  (6) 
11.2  (4) 
14.2  (4) 
13.7  (6) 
12.7  (6) 
* We wish to thank  Dr.  Dalldorf,  Division of Laboratories of the New York  State  De- 
partment  of Health  for these sera.  Both  sera were absorbed with  the pneumococcus "C" 
substance prepared from a  Type II culture. 
:~ Used 0.2 ml. of serum per skin site. 
§ Figure in parenthesis indicates the number of animals used for each determination. 
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SVIII N contained in a rabbit antiserum to Type III pneumococci. Each animal then re- 
ceived an intravenous injection of SVIII dissolved in saline or in fresh rat serum as desig- 
nated in the table. 
It is apparent that for the homologous reactions, an increase in the quantity 
of SVIII from 50 to 200/~g.  per rat produced no appreciable  change in  the 
PCA response,  confirming the  data  in  Table  I. Neither  did  the  presence of 
fresh  serum  intensify this  response.  In contrast, a  marked potentiation  was 
observed with the heterologous immune system upon the addition of hemolyti- 
cally active serum (cf.  also section D, below). 
TABLE IV 
The Effect of C' Component Reagents on the PCA Response in Normal Rats 
24/~g. SIII injected intravenously with 1 ml. of: 
Isotonic NaC]  ........................... 
Fresh guinea pig serum  .................... 
Ammonia-treated guinea pig serum ......... 
Specifically de-C' guinea pig serum ......... 
Fresh rat serum  .......................... 
Heated rat serum (56°C.--15 rain.) ......... 
Zymosan-treated rat serum  ................ 
C' components 
present* 
Rabbit anti-SIII N (R*- 175) 
injected intradei'mally, 
ktg. per skin site 
None 
1,  2,  3,  4 
1,  2,  3 
3 
1,  2,  3,  4 
3,  4 
1,  2,  4 
10.5  I  3.5  I  1.2 
Average response, mm.~ 
11.2 
23.5 
22.,5 
20.5 
18.8 
20.0 
11.0 
6.2 
16.2 
14.8 
13.8 
14.2 
8.2 
2.5 
0 
10 
11.8 
7.5 
11.5 
6.0 
0 
* As determined by the methods described in reference 12. 
Four rats used for each determination. 
C. The Effect of C' Component Reagents on PCA Reactions in the Albino Rat 
The observations recorded in the experiments with fresh sera were extended 
through the use of guinea pig and rat sera deficient in one or more of the four 
C' components. Although precise  quantitative  interpretations  cannot be  ap- 
plied to data obtained with the use of these reagents, it was anticipated that 
information might emerge which would facilitate the identification of the sub- 
stance  in  normal  serum  which  potentiates  the  PCA  response.  The  data  in 
Table  IV summarize  the  results  obtained  in  one  experiment  of this  type in 
which PCA reactions were elicited with 24 t~g. SIII and varying quantities of 
rabbit  anti-SIII N  (R3--175).  As in  the  experiment  described  immediately 
above,  the  various  reagents  were  injected  intravenously  together  with  the 
antigen-dye mixture. Analogous results were obtained in replicate experiments 
when  12  t~g. SIII were  injected  with  fresh,  heated,  hydrazine- or zymosan- 
treated serum. As shown in Table IV, each of the serum reagents which aug- 
mented  the  PCA reactions was shown to possess C'3 activity. Hemolytic C' 820  MECttANIS~  OF  HYPERSENSITIVITY PttENOMENA.  II 
titrations on sera of one group of normal rats 2 hours prior to, and 15 minutes 
after the intravenous injection of 2 ml. of fresh guinea pig serum showed an 
increase in activity from an average value of 45.9  C'I-Is0 per ml. to 79.8 C'I-I60. 
With respect to the C' component reagents, the presence of C'3 was verified 
by two  titration procedures,  the  classical method described in reference  12, 
and the use of sensitized erythrocytes reacted with Cq, C'4,  and C'2  as out- 
lined in reference 28. In some preparations of heated serum, C'3 activity could 
not be demonstrated with the latter technique because of its anticomplementary 
activities.  Destruction of C'3  by treatment with zymosan abolished the  en- 
hancing property  of fresh  whole  serum.  These  data may be  interpreted  to 
indicate that the third component of C' participates in potentiating PCA reac- 
tions in  the rat. 
D. Paralldisms between in Vitro Fixation of C  ~  and PCA Induction by 
Antigen and Antibody 
1.  In  Homologous  and  Cross-Reacting  Immune  Systems.--Previous  studies 
have shown that the  C'-fixing potency of a  cross-reacting polysaccharide or 
protein immune system is markedly inferior to that of the homologous reac- 
tants on an equivalent weight basis,  particularly in experiments carried out 
at 37°C.  (29).  It was therefore considered pertinent to the problem at hand, 
to  compare the efficacy of homologous and heterologous immune systems in 
provoking  PCA  reactions.  Quantitative  precipitin  analyses  of  rabbit  anti- 
pneumococcus Type III serum R3-- 164 with SIII and SVIII at 0°C. indicated 
levels of 1.93 rag. anti-SIII N  and 0.210 rag. of anti-SVIII N per ml. of serum. 
C' fixation assays at 37°C.  were  also  carried out with these reagents in the 
presence of diluted rat C' containing 5 C'Hs0 (30). Whereas 0.09 t*g. of homol- 
ogous antibody N fixed 4 of the 5 C' units in the reaction with 0.005 t~g. SIII, 
the same degree of C' fixation with SVIII required 2.9 t~g. of cross-reacting 
antibody N  and 0.04 #g. of the Type VIII polysaccharide. The efficiency of 
the heterologous antibody was therefore less than 5 per cent of the homologous 
reactants under these conditions. 
When  PCA  was  studied  in  rats,  the  homologous  SIII-anti-SIII  reaction 
with serum R3-164 yielded results which were entirely comparable with those 
summarized in Table I. Further, when 100 #g.  of SIII was injected intrave- 
nously, PCA reactions could be elicited with as little as 0.48  #g. of homologous 
antibody N. In contrast, the same amount of SVIII failed to provoke demon- 
strable skin blueing even with 20.0 tzg. of cross-reacting antibody N. When the 
SVIII level was doubled, to 200 tLg., perceptible responses of 6 ram. were ob- 
served with 2.5 to 5.0 #g. of heterologous antibody N. These results are anal- 
ogous to those reported for systemic anaphylaxls in the guinea pig and have 
been interpreted solely on the basis that fewer combining groups are available 
for the cross-reaction than for the interaction between SIII and its homologous OSLER, ttAWRISIAK,  OVARY, SEQUEIRA, AND  BIER  821 
antibody (27). It is noteworthy, however,  that  the diminished  efficiency of 
the heterologous  immune system in provoking  local or general  anaphylactic 
reactions,  is  also  associated  with a  markedly reduced  C~-fixing potency. In 
experiments  with  rabbit  anti-pneumococcus  Type  VIII  serum,  the  SVIII 
polysaccharide  yielded PCA reactions  that were entirely comparable  to those 
shown in Table I for the SIII immune system. 
2. In the Reaction of Horse Anti-Pneumococcus Antibody with the Homologous 
Polysaccharide.--In  a preliminary report of this study, note was taken of the 
slight but unexpected  diminution of PCA reactions and C' titers that was ob- 
served following the injection of horse anti-pneumococcus serum and its homol- 
ogous polysaccharide  into the rat (7). This finding seemed to conflict with the 
present working hypothesis that C' participates in PCA since it has frequently 
been reported that the horse polysaccharide immune system does not fix guinea 
pig C' (31-34). In view of the in vivo behavior of this system, the question was 
reinvestigated.  Complement  fixation  tests  of  the  conventional  type  with 
5 C'I-~0 (30) confirmed the earlier findings in showing that as much as 50 #g. 
of horse Type III or Type VIII anti-pneumococcus N failed to yield evidence 
of fixation  with a  wide range of SlII or SVIII concentrations respectively. 
However,  when  the C' fixation  studies were repeated in  the presence  of 50 
or  100  CPHs0 (35), clear evidence of specific fixation was obtained.  Thus, 25 
vg. of antibody N  from horse anti-pneumococcus  Type III serum  (No.  141) 
reacting with SlII in the cold for 20 hours fixed 24 out of the 100 C'I-~0 initially 
available.  The horse antiserum of Type VIII specificity appeared to be more 
reactive in this regard since 21 t~g. of anti-SVIII N fixed 28 of 50 C~Hs0 when 
reacted with SVlII at 37°C. for 90 minutes. 
The data in Table V show that both of these horse sera also conferred PCA 
reactions in the rat and further, the Type VIII antibody produced  more in- 
tense responses than did the horse anti-SIII at equivalent levels of antibody 
N. These findings provide additional evidence for the association of C  ~  fixation 
and PCA reactions. Moreover,  the horse anti-pneumococcus  Type VIII serum 
showed considerable cross-reactivity  with SIII in that 128 vg. of anti-SIII N 
per ml. of serum was precipitated with the heterologous polysaccharide,  SIII. 
Despite the presence of this precipitable  cross-reacting antibody, the C~-fixing 
potency  of  the  heterologous  system  comprising  SIII  and  anti-SVIII  was 
virtually negligible at 37°C. Thus, in a reaction mixture containing 50 C'H~0, 
5 t~g. of the cross-reacting antibody N  fixed only 4 C'Hs0, a value barely ex- 
ceeding the experimental  error of the method (cf. also references 35, 29). This 
inefficiency in fixation of C' was accompanied  by the failure  to obtain PCA 
reactions in rats receiving 5 #g. of heterologous antibody N (average response, 
2 mm. in 4 rats). With 13 t*g. of cross-reacting  antibody N, 5 mm. PCA re- 
sponses were observed. Data of this type would seem to denote that the antigen- 
antibody reaction in itself does not necessarily suffice to evoke a PCA reaction. 822  MECHANISM OF  HYPERSENSITIVITY  PHENOMENA. II 
3.  In  the  Reaction  of  Rabbit  Anti-Ribonudease  with  Ribonudease  and  the 
Acetylated and Guanidinated Derivatives  of the Enzyme.--The availability of an 
antiserum  to  bovine ribonuclease  afforded  a  further  opportunity  to  confirm 
the  association of PCA reactions with  the fixation of C'. These studies  were 
carried out with the serum of rabbit 172-1 containing 250  t~g. anti-ribonuclease 
N  per ml.  1 This antiserum,  at a  level of 2.5  ug.  antibody N, fixed 81  of  100 
guinea  pig  C'Hs0 in  reactions  carried  out  at  0°C.  with  ribonuclease  and  70 
CtI-~0 with  the  guanidinated  derivative of the  enzyme.  The  aeetylated ribo- 
nuclease fixed only 14 C'Hs0 with the same antibody level under optimal con- 
ditions.  It could also be demonstrated that  the acetylated enzyme combined 
TABLE  V 
Induction of PCA Reactions in Rats by Horse Anti-Pneumococcus  Sera Reacting 
with Homologous Polysacckarides 
Sera*--Horse  anti-pneumococcus Type III 141  (1.07 rag. anti-SIII N  per  ml.). Horse 
anti-pneumococcus Type VIII 649 (0.702 mg. anti-SVIII N per m]. and 0.128 rag. anti-SIII 
N per ml.) 
sac~tYide 
injected 
intravenously 
102 SIII 
102 SIII 
24 SVIII 
100 SVIII 
Horse anti-SIII N  (141), #g. per skin site  [  Horse anti-SVIII N  (649),/~g. per skin site 
2o  I  lO  i  s  2  I  ,o  is3l  12sl  1o 
Avera  • diameter  of response, ram. 
16 (8)~ 11.2  (8) 8.5 (8) 
2 (4)  0  (4) 0  (4)  I 
2  (4) 
(6)  (4)  (6)  I  0  (4)§ 24  9  17  8 (4) 
I 
2  (4) 
S.3  (6) 
*  We wish  to thank Dr. Dalldod,  Division  of  Laboratories  of  the  New York State  De- 
partment  of  Health  for  these  sera. 
Figure  in  parenthesis  indicates  the  number  of  animals  used  for  each  determination. 
§  The  serum  injected  into  these  rats  contained  no  precipitable  anti-Sill  following  specific 
absorption  of  the  antibody  with  SIII. 
with the antibody and inhibited  fixation  of C' on subsequent addition of the 
native  enzyme. These experiments confirmed similar  and prior  observations  by 
Van Vunakis eta/.  (36). 
As seen in  Table VI, the PCA  reactions  paralleled  the in vitro  fixation  of C' 
by the three antigen  preparations. The acetylated enzyme fixed  very few units 
of C  p  and elicited  minimal skin blueing only with 120 pg. of antigen N. In 
contrast,  the native enzyme was far more efficient  in both rcspects while the 
guanidinatcd derivative showed a slightly  diminished C'-fixing  potency and a 
moderately reduced capacity for the induction of PCA. It may also  be noted 
that the acetylated ribonuclease preparation did  provoke blueing of  guinea pig 
i  We are indebted  to Drs.  Helen van Vunakis  and Lawrence Levine  of  the New York 
State  Department of  Health  for  a generous  supply  of  these  reagents. OSLER,  HAWRISIAK,  OVARY~ SEQUEIRA~ AND  BIER  823 
skins  but  to  a  lesser degree than  did  the native enzyme. Thus,  guinea  pigs 
prepared with 0.05 and 0.025 gg. of anti-ribonuclease N  and challenged with 
0.25  ug.  of  either  ribonuclease  N  or  its  acetylated  derivative  yielded  skin 
reactions averaging  13 and  10 mm. for the native enzyme. The reactions ob- 
tained  with  the  acetylated preparation  averaged  3  and  0  mm.  at  the  same 
antibody levels. 
4. In Normal Rats Following the Intravenous  Injection of Zymosan.--Several 
experiments such as the one summarized in Table IV, indicated that zymosan- 
treated guinea pig and rat sera failed to potentiate PCA reactions in normal 
rats.  In  view of the destructive action  of zymosan on  C'3,  an  attempt  was 
TABLE  VI 
Comparison of PCA Responses and C'-Fixing Potency of Rabbit A nti-Ribonuaease 
(Serum 171-1) Reacting with the Native and Modified Enzyme Preparations 
Antigen N 
injected intravenously 
~g. 
Ribonuclease  30 
Acetylated 
ribonuclease 
~uanidinated 
:ibonuclease 
PCA reactions 
Rabbit anti-ribonuclease  N,/.tg. per skin site 
,26  [  63  I  3,  [  ,6 
Average diameter  of skin response, ram. 
15 
5 
120  5  (3) 
6O  1  (3) 
30 
30  14.6  (11) 
15  5.4  (11) 
14.8  (13)* 
11.o  (13) 
0  (6) 
3  (3) 
1.7  (13) 
o.3  (13) 
6.1  (11) 
2.5  (11) 
II.0 
7.0 
0 
3 
0 
1.2 
(13)  7.o  (13) 
(13)  s.1  (13) 
(6)  0  (6) 
(3)  1  0) 
(13)  0  (13) 
(13)  1  (13) 
(11)  3.2  (11) 
(11)  0  (11) 
Maximal C' H60 
fixed at 0°C. 
with 2.5/zg. 
anti* 
rlbonuclease  N 
81 
14 
70 
* Figure in parenthesis indicates the number of animals used for each determination. 
made to extend these observations. Preparations of zymosan which effectively 
destroyed  C'3  in  fresh  rat  serum,  were  injected  intravenously  into  normal 
rats.  Some of the animals were bled for hemolytic C' estimations and others 
were used to study the effect of zymosan on the PCA response. The results of 
these  experiments,  as  outlined  in  Table  VII,  again  demonstrate  a  parallel 
diminution in the in vitro lytic activity and in the response of the rat to cuta- 
neous anaphylactic reactions. 
5. In Rats Rendered C'-Deficient by an in Vivo Antigen-Antibody  Reaction.-- 
An earlier study demonstrated than an in vivo antigen-antibody reaction re- 
sulted  in  a  concomitant  reduction of both  hemolytic C'  activity and  PCA 
responsiveness  (7).  These  observations  were  corroborated  by  the  zymosan 824  MECHANISAI  OF  HYPERSENSITIVITY  PHENOMENA.  II 
studies described immediately above. The use of immune reactants was sub- 
jected to a more detailed study in an effort to explore the relationship between 
circulating C' levels and reactivity to cutaneous anaphylaxis. 
(a)  Time  course  studies  of circulating  C'  levels following  an  in  vivo  antigen- 
antibody  reaction:  The data  in Table VIII summarize the results obtained in 
three  experiments  wherein  hemolytic  activity  measurements  are  given  for 
varying intervals of time following an intravenous injection of rabbit antibody 
and an intravenous or intraperitoneal administration of the homologous antigen. 
The several experiments differ with respect to the specificity and quantity of 
immune reactants utilized for initiating the C' depletion process. When both 
antigen and antibody are injected by the intravenous route, an immediate fall 
TABLE VII 
The Effect of Intravenous ln3e~don of Zyraosan on C' Levels and PCA Responses 
in Albino Rats 
[  No. C'HI* per ml. 
zymo- ]  ........... 
inTa-  Before  2 hrs. after 
I 
injected 
re-  zymosan  zymosan 
nonsly [  injection  injection 
......  [ 
m~.  I  I 
~.0"  ~  (4)*  26  (4) 
2.5  (4)  11  (4) 
5.0  34  (4)  10  (4) 
10.0  41  (10)  7  (11) 
PCA reactions, #g. antibody N  injected per skin site 
Rabbit anti-Ea  1  Rabbit anti-SIH 
i i  ,,I  12 ,0,  I  35  1,2 
Average diameter of skin response, ram. 
1 
14  (9)  I 9.4  (9)  I 5  (6)  17.1 (6) 
! 
1  0.6  o  (19) 
11.3 (6) 
o  (8) 
o  (12) 
4.5  (6) 
o  (8) 
0  (12) 
* The zymosan suspension was injected 30 minutes prior to the intravenous rejection of 
the dye-antigen mixture, 
~; Figure in parenthesis indicates the number of rats used for each determination. 
in the hemolytic activity of the sera is apparent. However, when the antigen 
is injected intraperitoneally, the decrease occurs more gradually, as might be 
expected. The latter schedule was selected for subsequent studies to ascertain 
the association of the decline in C' activity with cutaneous reactivity to passive 
anaphylaxis. The data in Table IX summarize the results of one such experi- 
ment in which PCA and C' levels were studied at various intervals following 
the  C'  depletion  procedure.  A  marked  parallelism  is  apparent  between  the 
circulating C' levels and the susceptibility of the animals to PCA. Thus, within 
15  minutes  after  the  intraperitoneal  injection  of  ovalbumin,  C'  levels  are 
perceptibly lower and PCA reactions are essentially abolished at antibody N 
levels of 0.4 and 1.2 ~g. per skin site. The simultaneous decline in both activities 
continues for at least 2 hours before a  return to normal values is observed in 
the PCA responses as well as in the hemolytic C' activity. OSLER~  HAWRISIAK,  OVARY, SEQUEIRA1  AND  BIER  825 
TABLE  VIII 
Hemolytic C' Levels in Rats Following in  Vivo Antigen-Antibody  Reactions 
Time after initiation 
of in t/,o 
immune reaction 
]zf$  ° 
0 
0.13 
0.17 
0.25 
1.0 
1.15 
2.0 
2.7 
3.4 
4.0 
4.7 
5.0 
6.2 
7.5 
8.0 
22.4 
i 
Rabbit anti-Ea N; 500/~g.  Rabbit anti-SIII N; 420/zg. !  Rabbit anti-SIII N; 
intravenously* Ea  intravenously  SIII, 53/~g. [210/~g. intravenously  SIII, 
280/~g. N, intravenously  intraperitoneally  i  53/~g. intraperitoneally 
Average C'H~e  per ml. 
41  (28) 
3  (4) 
7  (4) 
14  (4) 
19  (4) 
29  (4) 
42  (4) 
32  (20) 
25  (4) 
19  (4) 
4  (4) 
4  (4) 
13  (8) 
42  (6) 
48  (2) 
1o  (4) 
4  (4) 
20  (4) 
30  (4) 
22  (2) 
* Rabbit anti-hen ovalbumln 6456 contained 0.65 mg. of antibody N  per ral. Ea,  twice 
recrystailized hen ovaibumin obtained from Worthington Biochemical Company,  Freehold, 
New Jersey. 
TABLE  IX 
Effect oJ an in Vivo Immune Reaction  on levels of Serum C' and PCA Responsiveness 
Antibody injected intravenously--200 ~tg. rabbit anti-Ea N  (serum  6456).  Antigen in- 
jected intraperitoneaily--80/tg.  Ea  N. 
Time after 
Ea-anti-Ea injections 
0 
0.25 
O. 75 
2.0 
4.0 
6.0 
Rabbit anti-SIII N (lh -- 175)~injected  intradermally,/zg, per skin site 
Average C'H~o 
per ml. 
41  (8)~ 
24  (6) 
>4  (4) 
9  (4) 
25  (4) 
26  (8) 
~o.s  I  3.s  [  ~.2  0.4 
Average  response, ram.* 
18  (4) 
16  (3) 
8  (4) 
2.8  (16)§ 
21  (3) 
16  (3) 
14.8  (4)  8.3  (4) 
6  (3)  2.7  (3) 
5  (4)  0  (4) 
1.6  (16)  0.3  (16) 
15  (3)  12  (3) 
17  (3)  4  (3) 
s  (4) 
0  (3) 
0  (4) 
0.2  (16) 
6  (3) 
3  (3) 
* PCA reactions provoked with 24 pg. SIII. 
2~ Figure  in parenthesis indicates the number of  rats for  each determination.  Different 
animais were used for C' and PCA estimations. 
§ The results of several experiments are combined. In many instances the PCA reactions 
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A  further demonstration of the possible dependence of PCA reactivity on 
the hemolytic activity of the animal's serum is indicated by the data in Table 
X. In these experiments, the PCA tests were all carried out at 2 hours after 
the  in  ~ivo  decomplementation  procedure.  However,  varying  quantities  of 
immune reactants were employed, thus providing a graded diminution of both 
C' activity and PCA responsiveness. The intensity of the PCA response varied 
not only with the hemolytic activity of the C' but also with the quantity of SIII 
used  to provoke the skin reaction. The data  thus show  that  for a  given C' 
TABLE X 
Comparative Studies of C' Le~ds and PCA Reactions in C'-Deficient Rats 
ktg. Ra anti-Ea N* 
#g. EaN 
used for 
decomplementation 
100/~ 
200/~ 
100/~ 
200/80 
400/200 
100/40 
20O/8O 
200/80 
2oo/80 
lOOO/lOO 
Average 
C'H~o per mt. 
22 
9 
22 
9 
4 
22 
9 
Sill used 
for challenge 
#g. 
12 
12 
24 
24 
24 
49 
49 
Rabbit anti-SII1 N injected  intradermally, ~g. per skin siU 
,o.,  I  3.,I,21o, 
Average response, mm. 
6  (4) 
2.8  (16) 
13.5 (4) 
4  (26) 
o  (3) 
3  (4) 
1.6  (16) 
9.2  (4) 
3.4  (14) 
o  (3) 
9.5  (4) 
9.5  (4) 
10.,5 (4)t 
11.8  (4)~/ 
o  (8)~ 
98 
196 
211 
14.5 (4) 
7.7  (8) 
16.8  (4) 
14.8  (4) 
0  (8) 
o  (4)  o  (4) 
0.3  (16)  0.2  (16) 
4.8  (4)  0  (4) 
1.5  (26)0.6  (14) 
o  (3)  i o  (3) 
3.2  (4)  0  (4) 
1.6  (4)  i o  (4) 
7.5(4)  i 
9.5  (4) 
o  (8)  [ 
* The rabbit antiserum in the amounts indicated, was injected intravenously and fol- 
lowed immediately  by an intraperitoneal injection of the antigen. 
Actually used 2.6 #g. antbSIII N at these sites. 
level, e.g., 9 C'Hs0 per ml., the PCA reaction is proportional to the amount of 
antigen; while at a  constant level of the latter, the existing C' activity would 
appear to influence the extent of skin blueing. Thus, when C' levels were re- 
duced to 3 C'I-~0 per ml. with 1 mg. of antibody N, PCA reactions were not 
demonstrable even when more than 200/~g.  SIII were injected as the challenge 
dose. When the systemic immune reaction was reduced to 0.1  mg. of anti-Ea 
N, definite PCA reactions resulted when 24/~g. of SHI were injected and in 
these rats, the C' levels were substantially higher. 
In most of the experiments of this study, PCA reactions were elicited with 
rabbit antibody to the Type III pneumococcus reacting with the homologous 
polysaccharide, while C' depletion was effected through the interaction of hen OSLER, HAWRISIAK, OVARY, SEQUEIRA, AND BIER  827 
ovalbumin and homologous rabbit antibody. The data in Table XI show the 
effect of decomplementation with  several different  immune systems on PCA 
reactions induced with rabbit antibody to Type I  pneumococci and the corre- 
sponding  polysaccharide.  Similar  findings  resulted  when  rabbit  antibovine 
gamma globulin or albumin were used to elicit the cutaneous anaphylactic re- 
actions. 
It  should  be  mentioned  that  when  rats  were  injected  systemically with  a 
rabbit  polysaccharide immune system, depressions in cutaneous reactivity to 
ovalbumin were observed only with 400 to 500/zg. of antibody N. However, 
decomplementation with  200  ttg.  of anti-SI N  or anti-SIII N,  virtually ob- 
TABLE XI 
Effect of Variations in the Specificity of the in Vivo Immune Reactants on PCA 
Responses 
In ~ivo immune reactants* 
None ............................ 
Rabbit anti-Ea +  Ea .............. 
Rabbit anti-BGG +  BGG  .......... 
Rabbit anti-SIII +SIII  ........... 
Horse anti-SIII A- SIII§  ........... 
Rabbit anti-SI N,/zg. per skin site 
s.4  t  1.1  [  o.4  [  o.1 
Average diameter of skin response, mm.~ 
12.5 
4.2 
3 
5.2 
11.1 
11.5  9.8 
2.5  0 
2.5  2.5 
3  1.5 
5.2  1.2 
3.8 
0 
0 
0 
0 
* In each case 200/zg. of antibody N were injected intravenously and a slight excess of 
antigen intraperitoncally. 
:~ Four rats were used for each experiment. 
§ The C  ~  titers in these  rats  diminished  from 47 to 34.5 C'H60 per ml. in 2 hours after 
the systemic immune reaction. 
literated PCA reactions to immune systems other than Ea-anti-Ea as typified 
by the data in Table XI. 
(b) In C-depleted rats injected with C' component reagents: The data in Table 
IV indicated that PCA reactions in normal rats were enhanced when various 
C' component  preparations  were  substituted  for the  saline  diluent  injected 
with  the  antigen.  The possibility of confirming these  findings in  C'-depleted 
animals  was explored in  experiments  which are  summarized  by the  data  in 
Table XII. In these studies,  the rats received an intravenous injection of 200 
/~g. of rabbit anti-ovalbumin N  and an intraperitoneal inoculation of 80/~g. of 
ovalbumin  N.  The  designated  amounts  of  SIII polysaccharide,  mixed  with 
Evans blue, were diluted in saline or in one of the several serum preparations 
as indicated in Table XII and injected intravenously, 2 hours after preparation 
of the  skin sites  with  rabbit  anti-SIII. 
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also showed an enhanced response when fresh, heated (56°C.--15 minutes), or 
ammonia-treated  serum  was  incorporated  in  the  antigen-dye  mixture.  The 
potentiation was  less pronounced  with  serum  heated for  1  hour  or absorbed 
with  washed  antigen-antibody  aggregates,  whereas  zymosan-treated  serum 
was ineffectual. The lack of enhancement  by zymosan-treated serum in these 
TABLE XII 
Restoration of PCA Reactions in C'-Depleted Rats 
SIII 
per rat 
~g. 
6 
6 
6 
12 
12 
12 
24 
24 
24 
24 
24 
24 
24 
SIII injected intravenously with 1 mE of: 
Isotonic saline 
Fresh guinea pig serum 
Heated guinea pig serum (56°C.-- 
60 rain.) 
Isotonic saline 
Fresh guinea pig serum 
Heated guinea pig serum (56°C.  - 
60 rnin.) 
Isotonic saline 
Fresh rat or guinea pig serum;~ 
Heated serum§ (56°C.--15 rain.) 
Heated serum§ (56°C.--60 min.) 
Ammonia-treated rat serum 
Zymosan-treated rat serum 
Decomplemented  serum[] 
Rabbit anti-SIIl N,/~g. per skin site 
I0.5  3.5  [  1,2  [  0.4 
Avers  e diameter of skin response, •m. 
0  (8)* 
8.6  (12) 
2.5  (4) 
1.8 
3.5 
4 
(12) 
(20) 
(8) 
4.3  (34) 
10.4  (44) 
10.5  (11) 
5.5  (14) 
9.9  (8) 
3.9  (7) 
6.1  (12) 
o  (8)  o  (8)  o 
7.2  (12)  5.1  (12) 
2.5  (4)  0.5  (4) 
1.1  (12)  0.4  (12) 
4.1  (20)  1.8  (20) 
4.5  (8)  2.s  (8) 
3.5  (22)  1.4  (34) 
6.6  (20)  3.9  (32) 
5.8  (11)  3.7  (11) 
4.9  (14)  2.4  (14) 
7.5  (8)  6.0  (8) 
2.1  (7)  1.4  (7) 
4.2  (12)  1.5  (12) 
(8) 
3  (12) 
3  (4) 
0.3  (12) 
0.5  (20) 
0.8  (8) 
0.4  (22) 
0.5  (20) 
2  (11) 
0.7  (12) 
0  (8) 
0  (7) 
0  (12) 
* Fi ,,ure in parenthesis indicates the number of animals used for each determination. 
:~ The injection of fresh guinea pig serum in one group of these rats increased the number 
of C'I-~ from a mean value of 9 to 37 per ml. 
§ Sera from rats or guinea pigs yielded essentially similar results. 
[[ Serum  treated with washed  specific precipitate (200 /zg. rabbit anti-bovine gamma 
globulin N plus 24 ~tg. of homologous antigen N per ml. of serum). 
animals cannot be adequately explained on the basis of our present knowledge 
concerning all the factors which might influence PCA. Clearly, this observation 
necessitates further study. 
JE. The Association  of Variations in PCA Reactivity to Blueing of the Rat Skin 
by Other Than Immune Reagents 
It has been established that the intravenous injection of a dye such as Evans 
blue may be utilized to demonstrate  local permeability changes in cutaneous OSLER,  I'IAWRISIAK~ OVARY, SEQUEIRA t  AND  BIER  829 
sites inoculated with a variety of pharmacologically active substances. Several 
reagents  (histamine,  48/80,  dextran,  serotonin,  normal  rat  and  guinea  pig 
serum) were tested to ascertain whether the variations in PCA reactivity ob- 
served  in  this  study could  be  attributed  to  an  altered  permeability of  the 
minute vessels of the skin induced by the experimental procedures  (37-39). 
The evidence obtained in numerous trials clearly indicated that the blueing of 
the rat skin resulting from these reagents was neither enhanced nor suppressed 
in those animals showing an altered PCA reaction in response to the injection 
of fresh serum, C' component reagents or the in vivo decomplementation pro- 
cedure. 
DISCUSSION 
The proposed hypothesis linking C' and PCA in a  causal relationship can 
be considered in terms of three subsidiary problems, (a) the detection of a host 
factor which, together with antigen and antibody, influences the outcome of 
the cutaneous response, (b) the identification of this reactant as hemolytic C r, 
and (c) the elucidation of its role as an essential mediator or as an intensifier of 
the local anaphylactic reaction. 
The evidence accumulated thus far, clearly suggests that the host supplies 
one of the reagents which participates in PCA. This conclusion emerges from 
data such as that in Tables I, II, and IV (of. also Figs. 2 and 3) which show 
that the intravenous injection of fresh serum is associated with a considerable 
increase of the allergic reaction. Moreover, this effect appears to be specifically 
related to the antigen-antibody reaction at the skin site since the intravenous 
injection of serum did not intensify the blueing of the skin produced by intra- 
dermal injections of histamine, 48/80, dextran, serotonin, or fresh serum. 
Characterization of the serum constituent which participates in the induc- 
tion of PCA, as C', presents a somewhat more complex problem. In part, this 
difficulty stems from the necessity of defining C' mainly in terms of operational 
considerations. On this basis, PCA may be regarded as the final step of a series 
of events initiated as an in viro C' fixation reaction carried out in the presence 
of a large excess of C' supplied by the circulating blood in continuous contact 
with the reaction site. A logical consequence of this analogy implies that the 
present  findings cannot be  adequately interpreted  in  terms  of  the  antigen- 
antibody reaction per se.  The  first pertinent  line of evidence relates  to  the 
magnitude and sensitivity of the allergic response as influenced by the addition 
of hemolytically active sera.  In a  comparable fashion, the extent of in  vitro 
C '  fixation also varies directly with the level of C' initially available for the 
reaction (40).  Furthermore, a sharp diminution in circulating C p levels induced 
in the rats by zymosan or by specific immune aggregates of known reactivity, 
is  accompanied by a  pronounced decline  in  the  PCA  response  (Table  VII, 
IX, and X). The two events follow a similar time course and, in addition, PCA 830  MECHANISM  OF  HYPERSENSITIVITY  PHENOMENA.  II 
reactions are onty moderately suppressed when C' levels are partially reduced 
(Tables IX, X,  and XI). As shown by the data in Table X  and Fig.  1,  the 
extent of the PCA reaction can be varied in either direction by simultaneous 
manipulation  of  the  hemolytic potency of the  host's  serum  or  the  level  of 
antigen used for the challenge.  When the hemolytic activity of C' is reduced 
to barely detectable levels (Table X and reference  7), PCA reactions are abol- 
ished and fail to appear even with large excesses of antigen. 
Experiments  with  immune  systems of varying  C'-fixing  potencies provide 
further evidence in accord with the proposed mechanism  (Tables V and VI). 
Thus,  the correlation between the efficiency of an  immune  system to fix C' 
and to provoke PCA has been found applicable in comparisons between horse 
and  rabbit  antipneumococcus  sera  reacting  with  their  homologous polysac- 
charities.  A similar  parallelism  has been demonstrated for rabbit anti-ribonu- 
clease  in its reaction with  three antigens,  the native enzyme as well  as the 
guanidinated  and  acetylated derivatives.  With  the  first  two proteins,  com- 
parable e~iciencies were noted in C' fixation  and PCA experiments. The acet- 
yiated ribonuclease  reacting  with  the same antibody fixed  little  C'  and  was 
markedly less able to call forth a PCA reaction. 
The studies with the homologous  and cross-reacting  pneumococcns-immune 
systems further support the analogy that  has been drawn between PCA and 
C' fixation.  It has been well established and confirmed  in this study that the 
cross-reaction between SVIII and rabbit antipneumococcus Type HI antibody 
is far less efficient than are the homologous reagents in the fixation of C' (Table 
III and reference 29). A similar  deficiency in PCA productivity has now been 
noted. It would appear difficult  to interpret these findings  solely on the basis 
that  the antigen  has fewer combining  groups available for  the  heterologous 
than  for the homologous antibody.  Under experimental  conditions in  which 
the  skin blueing  due  to  the homologous reactants  attained  maximal  values, 
(Table III) only the PCA reactions involving  the heterologous reagents were 
potentiated  by fresh  serum,  possibly because the  greater  availability  of  C' 
resulted in more efficient fixation  in the latter situation. With the homologous 
reactants,  fixation  may already have  reached  peak  levels  so  that  the  PCA 
reactions were thereby not altered (cf. reference 40). These data provide addi- 
tional  evidence  that  the  intravenous  serum  injection  did  not  produce  any 
generalized  changes in cutaneous permeability. 
The experiments summarized in Tables IV and XII and Fig. 3 were designed 
to fulfill some of the criteria  currently available for the identification of C'. 
There emerges from these data the indication that one of the limiting  factors 
for PCA is a  serum constituent which  is relatively heat-stable and possesses 
other properties associated with  C'3  such as susceptibility to destruction by 
zymosan but not by ammonia or hydrazine.  Furthermore, other reagents con- 
taining  C'3  activity,  such  as fresh  serum  depleted of hemolytic activity by OSLER,  HAWRISIAK~  OVARY~  SEQUEIRA~ AND BIER  831 
specific fixation,  also retain the capacity to enhance  PCA in the normal rat 
(Table  IV).  The failure  of this latter reagent to exert a similar  effect in C'- 
deficient rats (Table XII) may signify that adequate levels of all four C' com- 
ponents are  required  for this reaction as  in other immune processes which 
utilize C'. 
In an effort to ascertain whether the properdin  system (41) could be impli- 
cated  in the present findings,  titrations for properdin  activity were  carried 
out with two pools of serum, one obtained from normal and the other from C'- 
deficient rats. These assays were performed by Dr. Myron Leon according to 
the procedure  described in reference 42. Both serum specimens yielded essen- 
tially similar values. However, the paucity of data with regard to rat properdin 
levels as estimated by this technique,  prevents a  rigorous  exclusion of this 
factor at the present time.  ~ 
Evidence for the participation of C' in PCA is in line with previous reports 
based on studies involving other aspects of hypersensitivity such as the Schultz- 
Dale reaction (43, 44), activation of plasma proteolytic activity (6, 45), and 
the release of serotonin  and histamine from sensitized  tissues  (46, 47). The 
in  vivo  role of C' in cytotoxic phenomena emerges from the recent work  of 
Spear  (48) confirming  earlier  studies referable  to  the  Forssman antigen in 
chick embryos (49, 50). It should be noted, however, that Mongar and Schild 
have recently concluded  that C' does not participate in the release of hista- 
mine or in the anaphylactic contraction of smooth muscle (51). 
A  further  complexity  encountered  in  this  investigation pertains  to  the 
variability in response observed in different groups of rats. Although all animals 
were  uniform with respect  to  strain,  sex, weight,  and  source,  the  minimal 
amount of antigen required  to elicit PCA in normal rats received at different 
times, varied from 6 to 12 #g., and on rare occasions to 24 #g. For this reason, 
the differences between treatments were estimated from experiments performed 
on  the same day with a single shipment of rats. Statistical evaluations  3 esti- 
mated by using an error  term reflecting the variability of the measurements 
within individual experiments on a single day were in complete agreement with 
the qualitative interpretations given above. 
The analogy that has been advanced between the in vitro fixation of C' and 
PCA is limited in several respects. Both of these phenomena are highly complex 
and involve numerous intermediate stages, only one of which, the final event, 
has been subjected to systematic study. Moreover,  the present studies do not 
provide unequivocal proof as to the absolute requirement for C' in the initiation 
2 The authors are grateful to Dr. Leon for his cooperation in the performance and inter- 
pretation of these titrations. 
3 We are grateful to Dr. Paul Meier of the Department of Biostatistics of The Johns Hop- 
kins School of Hygiene and Public Health for his advice on the statistical treatment of these 
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of PCA despite the strongly suggestive evidence. Thus, serum C' may merely 
serve to potentiate the PCA reaction, not through the utilization of C' in the 
classical sense but rather by intensifying the interaction of antigen with anti- 
body as noted in specific  precipitation (52, 53).  In either case, the ability to 
inhibit or augment the local anaphylactic reaction by manipulation of serum 
C' levels creates further opportunities to elucidate some of the individual reac- 
tion steps whose cumulative effect produces the tissue injury associated with 
hypersensitivity reactions of the immediate type. 
SUMMARY 
Experiments are described indicating that the magnitude and sensitivity of 
the passive cutaneous anaphylaxis (PCA)  response in normal rats to a  given 
level of immune reagents, may be enhanced by the addition of hemolytically 
active sera. 
A similar enhancement in normal rats has been obtained with C  p component 
reagents possessing properties associated with the third component of C'. 
Parallelisms between in vitro fixation of C' and PCA induction by antigen 
and  antibody are  shown.  The  horse anti-pneumococcus system  has  low C'- 
fixing potencies and is also less efficient than the rabbit polysaccharide system 
in the induction of PCA. 
Findings of a  similar nature were observed in the reaction of rabbit  anti- 
ribonuclease with ribonuclease,  the  acetylated and guanidinated derivatives 
of the enzyme. 
The  injection of hemolytically active serum  into  C'-deficient rats  was ac- 
companied by a partial restoration of PCA. Restorative effects were also noted 
with heated and ammonia-treated serum. 
The return of hemolytic potency and responsiveness to PCA in C~-depleted 
rats, follow a  similar time course. 
The data presented indicate that the PCA reaction can be studied as a func- 
tion of at  least  three variables,  antigen,  antibody, and a  serum  constituent 
resembling C'. 
The authors gratefully acknowledge the excellent participation of Dr.  Joseph A.  Bauer 
in some of the initial experiments. 
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